Determination of circulating 25,26-dihydroxycholecalciferol in man by radioimmunoassay

L. J. Fraher, T. L. Clemens, S. E. Papapoulos, J. Redel, J. L. O'Riordan

Research output: Contribution to journalArticle

Abstract

A radioimmunoassay for 25,26-dihydroxycholecalciferol has been developed with an antiserum raised in a sheep, tritiated 1,25-dihydroxycholecalciferol as tracer and synthetic 25,26-dihydroxycholecalciferol as standard. The metabolite was purified from serum extracts by Sephadex LH 20 and high-pressure liquid chromatography; recovery was monitored with biologically generated, tritiated 25,26-dihydroxycholecalciferol. The mean ± SEM concentration of 25,26-dihydroxycholecalciferol in serum from 18 healthy subjects was 587 ± 65 pmol/l. Seven Asian patients with osteomalacia due to vitamin D deficiency had very low or undetectable (<96-231 pmol/l) circulating 25,26-dihydroxycholecalciferol concentrations. The metabolite was detectable in the sera from seven anephric patients (mean 262 ± 43 pmol/l), indicating that extrarenal sites for the 26-hydroxylation of 25-hydroxycholecalciferol exist in man. A strong positive correlation between the concentrations of 25-hydroxycholecalciferol and those of 25,26-dihydroxycholecalciferol in serum was obtained. Thus it appears that in man the production of this dihydroxy metabolite of vitamin D depends on the concentration of its precursor, 25-hydroxycholecalciferol.

Original languageEnglish (US)
Pages (from-to)257-263
Number of pages7
JournalUnknown Journal
Volume59
Issue number4
DOIs
StatePublished - Jan 1 1980
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this